Cargando…
Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
The etiology of Parkinson’s disease is poorly understood and is most commonly associated with advancing age, genetic predisposition, or environmental toxins. Epidemiological findings suggest that patients have a higher risk of developing Parkinson’s disease after ischemic stroke, but this potential...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867857/ https://www.ncbi.nlm.nih.gov/pubmed/35209932 http://dx.doi.org/10.1186/s40478-022-01327-6 |
_version_ | 1784656139421483008 |
---|---|
author | Lohmann, Stephanie Grigoletto, Jessica Bernis, Maria Eugenia Pesch, Verena Ma, Liang Reithofer, Sara Tamgüney, Gültekin |
author_facet | Lohmann, Stephanie Grigoletto, Jessica Bernis, Maria Eugenia Pesch, Verena Ma, Liang Reithofer, Sara Tamgüney, Gültekin |
author_sort | Lohmann, Stephanie |
collection | PubMed |
description | The etiology of Parkinson’s disease is poorly understood and is most commonly associated with advancing age, genetic predisposition, or environmental toxins. Epidemiological findings suggest that patients have a higher risk of developing Parkinson’s disease after ischemic stroke, but this potential causality lacks mechanistic evidence. We investigated the long-term effects of ischemic stroke on pathogenesis in hemizygous TgM83 mice, which express human α-synuclein with the familial A53T mutation without developing any neuropathology or signs of neurologic disease for more than 600 days. We induced transient focal ischemia by middle cerebral artery occlusion in 2-month-old TgM83(+/−) mice and monitored their behavior and health status for up to 360 days post surgery. Groups of mice were sacrificed at 14, 30, 90, 180, and 360 days after surgery for neuropathological analysis of their brains. Motor deficits first appeared 6 months after focal ischemia and worsened until 12 months afterward. Immunohistochemical analysis revealed ischemia-induced neuronal loss in the infarct region and astrogliosis and microgliosis indicative of an inflammatory response, which was most pronounced at 14 days post surgery. Infarct volume and inflammation gradually decreased in size and severity until 180 days post surgery. Surprisingly, neuronal loss and inflammation were increased again by 360 days post surgery. These changes were accompanied by a continuous increase in α-synuclein aggregation, its neuronal deposition, and a late loss of dopaminergic neurons in the substantia nigra, which we detected at 360 days post surgery. Control animals that underwent sham surgery without middle cerebral artery occlusion showed no signs of disease or neuropathology. Our results establish a mechanistic link between ischemic stroke and Parkinson’s disease and provide an animal model for studying possible interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-022-01327-6. |
format | Online Article Text |
id | pubmed-8867857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88678572022-02-25 Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein Lohmann, Stephanie Grigoletto, Jessica Bernis, Maria Eugenia Pesch, Verena Ma, Liang Reithofer, Sara Tamgüney, Gültekin Acta Neuropathol Commun Research The etiology of Parkinson’s disease is poorly understood and is most commonly associated with advancing age, genetic predisposition, or environmental toxins. Epidemiological findings suggest that patients have a higher risk of developing Parkinson’s disease after ischemic stroke, but this potential causality lacks mechanistic evidence. We investigated the long-term effects of ischemic stroke on pathogenesis in hemizygous TgM83 mice, which express human α-synuclein with the familial A53T mutation without developing any neuropathology or signs of neurologic disease for more than 600 days. We induced transient focal ischemia by middle cerebral artery occlusion in 2-month-old TgM83(+/−) mice and monitored their behavior and health status for up to 360 days post surgery. Groups of mice were sacrificed at 14, 30, 90, 180, and 360 days after surgery for neuropathological analysis of their brains. Motor deficits first appeared 6 months after focal ischemia and worsened until 12 months afterward. Immunohistochemical analysis revealed ischemia-induced neuronal loss in the infarct region and astrogliosis and microgliosis indicative of an inflammatory response, which was most pronounced at 14 days post surgery. Infarct volume and inflammation gradually decreased in size and severity until 180 days post surgery. Surprisingly, neuronal loss and inflammation were increased again by 360 days post surgery. These changes were accompanied by a continuous increase in α-synuclein aggregation, its neuronal deposition, and a late loss of dopaminergic neurons in the substantia nigra, which we detected at 360 days post surgery. Control animals that underwent sham surgery without middle cerebral artery occlusion showed no signs of disease or neuropathology. Our results establish a mechanistic link between ischemic stroke and Parkinson’s disease and provide an animal model for studying possible interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-022-01327-6. BioMed Central 2022-02-24 /pmc/articles/PMC8867857/ /pubmed/35209932 http://dx.doi.org/10.1186/s40478-022-01327-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lohmann, Stephanie Grigoletto, Jessica Bernis, Maria Eugenia Pesch, Verena Ma, Liang Reithofer, Sara Tamgüney, Gültekin Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein |
title | Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein |
title_full | Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein |
title_fullStr | Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein |
title_full_unstemmed | Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein |
title_short | Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein |
title_sort | ischemic stroke causes parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867857/ https://www.ncbi.nlm.nih.gov/pubmed/35209932 http://dx.doi.org/10.1186/s40478-022-01327-6 |
work_keys_str_mv | AT lohmannstephanie ischemicstrokecausesparkinsonsdiseaselikepathologyandsymptomsintransgenicmiceoverexpressingalphasynuclein AT grigolettojessica ischemicstrokecausesparkinsonsdiseaselikepathologyandsymptomsintransgenicmiceoverexpressingalphasynuclein AT bernismariaeugenia ischemicstrokecausesparkinsonsdiseaselikepathologyandsymptomsintransgenicmiceoverexpressingalphasynuclein AT peschverena ischemicstrokecausesparkinsonsdiseaselikepathologyandsymptomsintransgenicmiceoverexpressingalphasynuclein AT maliang ischemicstrokecausesparkinsonsdiseaselikepathologyandsymptomsintransgenicmiceoverexpressingalphasynuclein AT reithofersara ischemicstrokecausesparkinsonsdiseaselikepathologyandsymptomsintransgenicmiceoverexpressingalphasynuclein AT tamguneygultekin ischemicstrokecausesparkinsonsdiseaselikepathologyandsymptomsintransgenicmiceoverexpressingalphasynuclein |